 | • レポートコード：QYR2104Z4096 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、神経保護のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（無料抗炎症剤、ラジカル捕捉剤（抗酸化剤）、アポトーシス阻害剤、グルタメート拮抗薬（抗興奮毒性剤）、神経栄養因子（NTF）、刺激剤、金属イオンキレート剤、その他）、用途別市場規模（予防、治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・神経保護の市場動向 ・企業の競争状況、市場シェア ・神経保護の種類別市場規模（無料抗炎症剤、ラジカル捕捉剤（抗酸化剤）、アポトーシス阻害剤、グルタメート拮抗薬（抗興奮毒性剤）、神経栄養因子（NTF）、刺激剤、金属イオンキレート剤、その他） ・神経保護の用途別市場規模（予防、治療） ・神経保護の北米市場規模2016-2027（アメリカ、カナダ） ・神経保護のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経保護のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経保護の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経保護の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche、Eli Lilly and Company、Daiichi Sankyo Company、Allergan、Novartis、AstraZeneca、Dr. Reddy's Laboratories、Astrocyte Pharmaceuticals、Teva Pharmaceutical Industries、Biogen） ・結論 |
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases.
Market Analysis and Insights: Global Neuroprotection Market
The global Neuroprotection market size is projected to reach US$ 31370 million by 2026, from US$ 22980 million in 2019, at a CAGR of 4.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroprotection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroprotection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroprotection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroprotection market.
Global Neuroprotection Scope and Market Size
Neuroprotection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroprotection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Free Anti-Inflammatory Agents
Radical Trapping Agents (Antioxidants)
Apoptosis Inhibitors
Glutamate Antagonists (Anti-Excitotoxic Agents)
Neurotrophic Factors (NTFs)
Stimulants
Metal Ion Chelators
Others
Segment by Application
Prevention
Treatment
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche
Eli Lilly and Company
Daiichi Sankyo Company
Allergan
Novartis
AstraZeneca
Dr. Reddy’s Laboratories
Astrocyte Pharmaceuticals
Teva Pharmaceutical Industries
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroprotection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Free Anti-Inflammatory Agents
1.2.3 Radical Trapping Agents (Antioxidants)
1.2.4 Apoptosis Inhibitors
1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.6 Neurotrophic Factors (NTFs)
1.2.7 Stimulants
1.2.8 Metal Ion Chelators
1.2.9 Others
1.3 Market by Application
1.3.1 Global Neuroprotection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroprotection Market Perspective (2016-2027)
2.2 Neuroprotection Growth Trends by Regions
2.2.1 Neuroprotection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuroprotection Historic Market Share by Regions (2016-2021)
2.2.3 Neuroprotection Forecasted Market Size by Regions (2022-2027)
2.3 Neuroprotection Industry Dynamic
2.3.1 Neuroprotection Market Trends
2.3.2 Neuroprotection Market Drivers
2.3.3 Neuroprotection Market Challenges
2.3.4 Neuroprotection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroprotection Players by Revenue
3.1.1 Global Top Neuroprotection Players by Revenue (2016-2021)
3.1.2 Global Neuroprotection Revenue Market Share by Players (2016-2021)
3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuroprotection Revenue
3.4 Global Neuroprotection Market Concentration Ratio
3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2020
3.5 Neuroprotection Key Players Head office and Area Served
3.6 Key Players Neuroprotection Product Solution and Service
3.7 Date of Enter into Neuroprotection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroprotection Breakdown Data by Type
4.1 Global Neuroprotection Historic Market Size by Type (2016-2021)
4.2 Global Neuroprotection Forecasted Market Size by Type (2022-2027)
5 Neuroprotection Breakdown Data by Application
5.1 Global Neuroprotection Historic Market Size by Application (2016-2021)
5.2 Global Neuroprotection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neuroprotection Market Size (2016-2027)
6.2 North America Neuroprotection Market Size by Type
6.2.1 North America Neuroprotection Market Size by Type (2016-2021)
6.2.2 North America Neuroprotection Market Size by Type (2022-2027)
6.2.3 North America Neuroprotection Market Size by Type (2016-2027)
6.3 North America Neuroprotection Market Size by Application
6.3.1 North America Neuroprotection Market Size by Application (2016-2021)
6.3.2 North America Neuroprotection Market Size by Application (2022-2027)
6.3.3 North America Neuroprotection Market Size by Application (2016-2027)
6.4 North America Neuroprotection Market Size by Country
6.4.1 North America Neuroprotection Market Size by Country (2016-2021)
6.4.2 North America Neuroprotection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Neuroprotection Market Size (2016-2027)
7.2 Europe Neuroprotection Market Size by Type
7.2.1 Europe Neuroprotection Market Size by Type (2016-2021)
7.2.2 Europe Neuroprotection Market Size by Type (2022-2027)
7.2.3 Europe Neuroprotection Market Size by Type (2016-2027)
7.3 Europe Neuroprotection Market Size by Application
7.3.1 Europe Neuroprotection Market Size by Application (2016-2021)
7.3.2 Europe Neuroprotection Market Size by Application (2022-2027)
7.3.3 Europe Neuroprotection Market Size by Application (2016-2027)
7.4 Europe Neuroprotection Market Size by Country
7.4.1 Europe Neuroprotection Market Size by Country (2016-2021)
7.4.2 Europe Neuroprotection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neuroprotection Market Size (2016-2027)
8.2 Asia-Pacific Neuroprotection Market Size by Type
8.2.1 Asia-Pacific Neuroprotection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuroprotection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuroprotection Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuroprotection Market Size by Application
8.3.1 Asia-Pacific Neuroprotection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuroprotection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuroprotection Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuroprotection Market Size by Region
8.4.1 Asia-Pacific Neuroprotection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuroprotection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuroprotection Market Size (2016-2027)
9.2 Latin America Neuroprotection Market Size by Type
9.2.1 Latin America Neuroprotection Market Size by Type (2016-2021)
9.2.2 Latin America Neuroprotection Market Size by Type (2022-2027)
9.2.3 Latin America Neuroprotection Market Size by Type (2016-2027)
9.3 Latin America Neuroprotection Market Size by Application
9.3.1 Latin America Neuroprotection Market Size by Application (2016-2021)
9.3.2 Latin America Neuroprotection Market Size by Application (2022-2027)
9.3.3 Latin America Neuroprotection Market Size by Application (2016-2027)
9.4 Latin America Neuroprotection Market Size by Country
9.4.1 Latin America Neuroprotection Market Size by Country (2016-2021)
9.4.2 Latin America Neuroprotection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroprotection Market Size (2016-2027)
10.2 Middle East & Africa Neuroprotection Market Size by Type
10.2.1 Middle East & Africa Neuroprotection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuroprotection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuroprotection Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuroprotection Market Size by Application
10.3.1 Middle East & Africa Neuroprotection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuroprotection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuroprotection Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuroprotection Market Size by Country
10.4.1 Middle East & Africa Neuroprotection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuroprotection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Neuroprotection Introduction
11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 Daiichi Sankyo Company
11.3.1 Daiichi Sankyo Company Company Details
11.3.2 Daiichi Sankyo Company Business Overview
11.3.3 Daiichi Sankyo Company Neuroprotection Introduction
11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2016-2021)
11.3.5 Daiichi Sankyo Company Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Neuroprotection Introduction
11.4.4 Allergan Revenue in Neuroprotection Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neuroprotection Introduction
11.5.4 Novartis Revenue in Neuroprotection Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Neuroprotection Introduction
11.6.4 AstraZeneca Revenue in Neuroprotection Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Company Details
11.7.2 Dr. Reddy’s Laboratories Business Overview
11.7.3 Dr. Reddy’s Laboratories Neuroprotection Introduction
11.7.4 Dr. Reddy’s Laboratories Revenue in Neuroprotection Business (2016-2021)
11.7.5 Dr. Reddy’s Laboratories Recent Development
11.8 Astrocyte Pharmaceuticals
11.8.1 Astrocyte Pharmaceuticals Company Details
11.8.2 Astrocyte Pharmaceuticals Business Overview
11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2016-2021)
11.8.5 Astrocyte Pharmaceuticals Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Neuroprotection Introduction
11.10.4 Biogen Revenue in Neuroprotection Business (2016-2021)
11.10.5 Biogen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neuroprotection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Free Anti-Inflammatory Agents
Table 3. Key Players of Radical Trapping Agents (Antioxidants)
Table 4. Key Players of Apoptosis Inhibitors
Table 5. Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)
Table 6. Key Players of Neurotrophic Factors (NTFs)
Table 7. Key Players of Stimulants
Table 8. Key Players of Metal Ion Chelators
Table 9. Key Players of Others
Table 10. Global Neuroprotection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Neuroprotection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Neuroprotection Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Neuroprotection Market Share by Regions (2016-2021)
Table 14. Global Neuroprotection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Neuroprotection Market Share by Regions (2022-2027)
Table 16. Neuroprotection Market Trends
Table 17. Neuroprotection Market Drivers
Table 18. Neuroprotection Market Challenges
Table 19. Neuroprotection Market Restraints
Table 20. Global Neuroprotection Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Neuroprotection Market Share by Players (2016-2021)
Table 22. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotection as of 2020)
Table 23. Ranking of Global Top Neuroprotection Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Neuroprotection Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Neuroprotection Product Solution and Service
Table 27. Date of Enter into Neuroprotection Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neuroprotection Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Neuroprotection Revenue Market Share by Type (2016-2021)
Table 31. Global Neuroprotection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Neuroprotection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Neuroprotection Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Neuroprotection Revenue Market Share by Application (2016-2021)
Table 35. Global Neuroprotection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Neuroprotection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Neuroprotection Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Neuroprotection Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Neuroprotection Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Neuroprotection Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Neuroprotection Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Neuroprotection Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Neuroprotection Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Neuroprotection Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Neuroprotection Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Neuroprotection Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Neuroprotection Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Neuroprotection Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Neuroprotection Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Neuroprotection Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Neuroprotection Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Neuroprotection Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Neuroprotection Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Neuroprotection Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Neuroprotection Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Neuroprotection Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Neuroprotection Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Neuroprotection Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Neuroprotection Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Neuroprotection Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Neuroprotection Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Neuroprotection Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Neuroprotection Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Neuroprotection Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Neuroprotection Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Neuroprotection Market Size by Country (2022-2027) & (US$ Million)
Table 67. F. Hoffmann-La Roche Company Details
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche Neuroprotection Product
Table 70. F. Hoffmann-La Roche Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Neuroprotection Product
Table 75. Eli Lilly and Company Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Daiichi Sankyo Company Company Details
Table 78. Daiichi Sankyo Company Business Overview
Table 79. Daiichi Sankyo Company Neuroprotection Product
Table 80. Daiichi Sankyo Company Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 81. Daiichi Sankyo Company Recent Development
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Neuroprotection Product
Table 85. Allergan Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 86. Allergan Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Neuroprotection Product
Table 90. Novartis Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Neuroprotection Product
Table 95. AstraZeneca Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Dr. Reddy's Laboratories Company Details
Table 98. Dr. Reddy's Laboratories Business Overview
Table 99. Dr. Reddy's Laboratories Neuroprotection Product
Table 100. Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 101. Dr. Reddy's Laboratories Recent Development
Table 102. Astrocyte Pharmaceuticals Company Details
Table 103. Astrocyte Pharmaceuticals Business Overview
Table 104. Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 105. Astrocyte Pharmaceuticals Recent Development
Table 106. Teva Pharmaceutical Industries Company Details
Table 107. Teva Pharmaceutical Industries Business Overview
Table 108. Teva Pharmaceutical Industries Neuroprotection Product
Table 109. Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 110. Teva Pharmaceutical Industries Recent Development
Table 111. Biogen Company Details
Table 112. Biogen Business Overview
Table 113. Biogen Neuroprotection Product
Table 114. Biogen Revenue in Neuroprotection Business (2016-2021) & (US$ Million)
Table 115. Biogen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroprotection Market Share by Type: 2020 VS 2027
Figure 2. Free Anti-Inflammatory Agents Features
Figure 3. Radical Trapping Agents (Antioxidants) Features
Figure 4. Apoptosis Inhibitors Features
Figure 5. Glutamate Antagonists (Anti-Excitotoxic Agents) Features
Figure 6. Neurotrophic Factors (NTFs) Features
Figure 7. Stimulants Features
Figure 8. Metal Ion Chelators Features
Figure 9. Others Features
Figure 10. Global Neuroprotection Market Share by Application: 2020 VS 2027
Figure 11. Prevention Case Studies
Figure 12. Treatment Case Studies
Figure 13. Neuroprotection Report Years Considered
Figure 14. Global Neuroprotection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Neuroprotection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Neuroprotection Market Share by Regions: 2020 VS 2027
Figure 17. Global Neuroprotection Market Share by Regions (2022-2027)
Figure 18. Global Neuroprotection Market Share by Players in 2020
Figure 19. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotection as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Neuroprotection Revenue in 2020
Figure 21. Global Neuroprotection Revenue Market Share by Type (2016-2021)
Figure 22. Global Neuroprotection Revenue Market Share by Type (2022-2027)
Figure 23. North America Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Neuroprotection Market Share by Type (2016-2027)
Figure 25. North America Neuroprotection Market Share by Application (2016-2027)
Figure 26. North America Neuroprotection Market Share by Country (2016-2027)
Figure 27. United States Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Neuroprotection Market Share by Type (2016-2027)
Figure 31. Europe Neuroprotection Market Share by Application (2016-2027)
Figure 32. Europe Neuroprotection Market Share by Country (2016-2027)
Figure 33. Germany Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Neuroprotection Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Neuroprotection Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Neuroprotection Market Share by Region (2016-2027)
Figure 43. China Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Neuroprotection Market Share by Type (2016-2027)
Figure 51. Latin America Neuroprotection Market Share by Application (2016-2027)
Figure 52. Latin America Neuroprotection Market Share by Country (2016-2027)
Figure 53. Mexico Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Neuroprotection Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Neuroprotection Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Neuroprotection Market Share by Country (2016-2027)
Figure 59. Turkey Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Neuroprotection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 64. Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 65. Allergan Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 69. Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 70. Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 71. Biogen Revenue Growth Rate in Neuroprotection Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の神経保護市場 2021：企業別、地域別、種類・用途別 The Neuroprotection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…- 世界の固化防止剤市場 2021：企業別、地域別、種類・用途別 The Anti-caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の食品用固化防止剤市場 2021：企業別、地域別、種類・用途別 The Food Anti-caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の肥料固結防止剤市場 2021：企業別、地域別、種類・用途別 The Fertilizer Anti-Caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の飼料用固結防止剤市場 2021：企業別、地域別、種類・用途別 The Feed Anti-Caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…